Dive into Joseph Denby's presentation at NextGen Biomed 2026, where he shares a case study on delivering sustainable, efficient peptide manufacturing on scale through our advanced SPPS process optimizations.
CPC Scientific’s Rocklin facility is undergoing a major expansion to establish a 41,000 sq ft Center of Excellence for U.S.-based peptide API manufacturing. Construction is now underway—more updates coming soon.
Join us as we celebrate a proud milestone: the successful listing of Medtide Inc., parent company of CPC Scientific, on the main board of the Hong Kong Stock Exchange in June 2025. This moment marks a new chapter of growth, innovation, and global impact for our organization.
Sheri Ambriz, MBA took the stage at TIDES USA 2025 in San Diego, CA, to share insights on green approaches to peptide and peptide–oligonucleotide conjugate manufacturing.
Gain insights from Joseph Denby's rapid-fire Q&A spotlight at NextGen Biomed, where he explores the landscape of peptide and oligo APIs, as well as the role of green chemistry in manufacturing.
Watch Tim Nieters, MBA present a case study at TIDES USA 2024, showcasing process development & GMP manufacturing of DOTAGA-labeled peptide & POC-based products.
CPC Scientific celebrates its 20th anniversary, proudly serving the peptide therapeutic community for over 20 decades.
CPC Scientific celebrates its 20th anniversary, proudly serving the peptide therapeutic community for over 20 decades.
Started in 2010, the CPC symposium has now become an annual scientific event that brings together scientific leaders in the peptide-based therapeutics from biopharmaceutical industries and academia.
